Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
That's not microdosing
Cardiovascular benefits of GLP-1 The SELECT trial demonstrated that GLP-1 therapy rapidly reduces heart attacks and strokes. These cardiovascular benefits have long been hinted at in diabetes trials, but the magnitude observed in SELECT surprised even seasoned cardiologists
References: (1) Dorr RT, Ertl G, Levine N, Brooks C, Bangert JL, Powell MB, Humphrey S, Alberts DS
7% with placebo and 2% with dulaglutide
However, eligible individuals typically have a BMI of 30 or higher, or a BMI of 27 or higher, along with associated weight-related conditions such as type 2 diabetes, hypertension, or others
US$ 22.85
US$ 22.99
US$ 23.10
US$ 27.92
US$ 20.46
US$ 21.67
